Cycad Group Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 44
  • Portfolio
  • 10
  • Exits
  • 23
Exits

Cycad Group General Information

Description

Cycad Group is a venture capital firm focusing on investments in companies with enabling solutions, disruptive technologies and innovative products. It pursues investment opportunities in the areas of life sciences (e.g., therapeutics, medical devices, diagnostics and analytical tools), energy technologies, and advanced materials and chemical processes. The firm was founded in 2000 and is based in Santa Barbara, California.

Contact Information

Website
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 1270 Coast Village Circle
  • Suite 100
  • Santa Barbara, CA 93108
  • United States
+1 (805) 000-0000

Cycad Group Investments (44)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Formetrix 23-Aug-2018 Early Stage VC 00.00 Industrial Supplies and Parts Generating Revenue 0. 0000000 000000 00
00000000 05-Oct-2017 00000 00000 000.00 Biotechnology Generating Revenue
00000000 14-Sep-2017 00000 00000 00.000 Diagnostic Equipment Clinical Trials - General 0. 0000000 000000 00
00000 000000000000 21-Aug-2017 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable
00000000 000000000 03-Aug-2017 00000 00000 00000 Drug Delivery Profitable
000000000 0000000 13-May-2015 00000 00000 000.00 Surgical Devices Generating Revenue 000000 00000
00000000 15-May-2014 00000 00000 0000 Biotechnology Generating Revenue
00000000 08-May-2014 00000 00000 000.00 Diagnostic Equipment Clinical Trials - General 0. 0000000 000000 00
SOFIE 15-Oct-2013 Early Stage VC 000 Diagnostic Equipment Generating Revenue 0. 0000000 000000 00
Genocea Biosciences 02-Jul-2013 Later Stage VC 000.00 Drug Discovery Generating Revenue/Not Profitable
You’re viewing 10 of 44 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cycad Group Exits (23)

Company Name Exit Date Exit Type Exit Size
Ziopharm Oncology 05-Feb-2020 Secondary Transaction - Open Market 000.00
00000000 31-Aug-2018 000000000000000000 00000
00000 000000000000 03-May-2018 000 0000
000000000 0000000 20-Sep-2017 000000000000000000 00000
000000000 11-Sep-2017 000000000000000000 00000
0000000 0000000000 05-Feb-2014 000 0000
00000 000000 01-Feb-2014 000 00 00000000
000000 00000 01-Jan-2014 0000000000: 000000
SpectraFluidics 01-Jan-2014 Bankruptcy: Liquidation
Agile RF 01-Aug-2013 Out of Business
You’re viewing 10 of 23 exits. Get the full list »

Cycad Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Cycad Group Team (3)

Name Title Deals Funds Boards Office
K. Leonard Judson JD Co-Founder, President and Managing Director 0 0 Santa Barbara, CA
Robert Balch Senior Vice President 0 0 Santa Barbara, CA
Paul Glenn JD Chairman & Director 0 Santa Barbara, CA
To view Cycad Group’s complete team members history, request access »

Cycad Group Co-Investors (46)

Name With Exits Lead Partner Series Industry
Baillie Gifford 2 0 Series chart Industry bar
Bill & Melinda Gates Foundation 0 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 Series chart Industry bar
Allegheny Financial Group 0 0 Series chart Industry bar
The Invus Group 0 0 Series chart Industry bar
You’re viewing 5 of 46 co-investors. Get the full list »